School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Burning Rock Biotech Limited BNR

Healthcare · Diagnostics & Research

$15.49last close 2026-10-09 · market cap $163.36M · delayed data

Trailing returns

1M+29.19%
3M+32.39%
6M-4.68%
1Y+80.54%
5Y-90.46%

Basis: Adjusted daily closes.

What it does

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.

Open BNR in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies